Artwork

Conteúdo fornecido por The Michael J. Fox Foundation for Parkinson’s Research. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por The Michael J. Fox Foundation for Parkinson’s Research ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Player FM - Aplicativo de podcast
Fique off-line com o app Player FM !

Year of Momentum: What Parkinson’s Research Accomplished in 2024 (Webinar Audio)

57:55
 
Compartilhar
 

Manage episode 452244104 series 2456444
Conteúdo fornecido por The Michael J. Fox Foundation for Parkinson’s Research. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por The Michael J. Fox Foundation for Parkinson’s Research ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

With two new drugs approved by the FDA, a National Plan signed into law and many advances in our understanding of Parkinson’s disease, 2024 has been a transformative year in Parkinson’s research. Tune into audio from this month’s Third Thursdays Webinar to hear research experts from industry and academia talk with MJFF staff about the latest research on disease biology and emerging therapies.

Like our podcasts? Please consider leaving a rating or review and sharing the series with your community. https://apple.co/3p02Jw0

The Foundation’s landmark study, the Parkinson’s Progression Marker’s Initiative, also known as PPMI, is recruiting volunteers. Join the study that’s changing everything at michaeljfox.org/podcast-ppmi.

Mentioned in this episode:

In 2024 alone, The Michael J. Fox Foundation awarded 195 research grants aimed at medication, mobility, medical devices and more to scientists around the world, all in pursuit of better treatments and closing in on a cure. Your support can accelerate this urgent research. Donate by visiting michaeljfox.org/weneedyou.

  continue reading

204 episódios

Artwork
iconCompartilhar
 
Manage episode 452244104 series 2456444
Conteúdo fornecido por The Michael J. Fox Foundation for Parkinson’s Research. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por The Michael J. Fox Foundation for Parkinson’s Research ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

With two new drugs approved by the FDA, a National Plan signed into law and many advances in our understanding of Parkinson’s disease, 2024 has been a transformative year in Parkinson’s research. Tune into audio from this month’s Third Thursdays Webinar to hear research experts from industry and academia talk with MJFF staff about the latest research on disease biology and emerging therapies.

Like our podcasts? Please consider leaving a rating or review and sharing the series with your community. https://apple.co/3p02Jw0

The Foundation’s landmark study, the Parkinson’s Progression Marker’s Initiative, also known as PPMI, is recruiting volunteers. Join the study that’s changing everything at michaeljfox.org/podcast-ppmi.

Mentioned in this episode:

In 2024 alone, The Michael J. Fox Foundation awarded 195 research grants aimed at medication, mobility, medical devices and more to scientists around the world, all in pursuit of better treatments and closing in on a cure. Your support can accelerate this urgent research. Donate by visiting michaeljfox.org/weneedyou.

  continue reading

204 episódios

Todos os episódios

×
 
Loading …

Bem vindo ao Player FM!

O Player FM procura na web por podcasts de alta qualidade para você curtir agora mesmo. É o melhor app de podcast e funciona no Android, iPhone e web. Inscreva-se para sincronizar as assinaturas entre os dispositivos.

 

Guia rápido de referências